NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea · Delayed Price · Currency is KRW 1,257.00
-156.00 (-11.04%)
At close: May 18, 2026
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 33.7 billion as of May 19, 2026. Its market cap has decreased by -1.94% in one year.
Market Cap
33.70B
Enterprise Value
60.90B
Revenue
21.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,257.00
Market Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 33.70B, a decrease of -89.24%. That is a compound annual growth rate of -33.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 33.70B | -7.81% |
| Dec 30, 2025 | 36.56B | 12.79% |
| Dec 30, 2024 | 32.41B | -54.77% |
| Dec 28, 2023 | 71.66B | -38.23% |
| Dec 29, 2022 | 116.03B | -42.38% |
| Dec 30, 2021 | 201.38B | -46.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Psomagen | 59.73B |
| J2KBIO | 59.24B |
| Aptamer Sciences | 51.97B |
| ADBiotech | 48.81B |
| Epibiotech | 48.21B |
| Parataxis Korea | 44.13B |
| Poongjeon Pharmacy CO.,LTD. | 40.98B |
| Kainos Medicine | 35.56B |